BioForce Nanosciences Holdings, Inc.
BFNH
$0.60
$0.2466.67%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 481.60K | 473.20K | 472.70K | 471.90K | 472.20K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 481.60K | 473.20K | 472.70K | 471.90K | 472.20K |
| Operating Income | -481.60K | -473.20K | -472.70K | -471.90K | -472.20K |
| Income Before Tax | -481.60K | -473.20K | -472.70K | -471.90K | -472.20K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.48 | -0.47 | -0.47 | -0.47 | -0.47 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -481.60K | -473.20K | -472.70K | -471.90K | -472.20K |
| EBIT | -481.60K | -473.20K | -472.70K | -471.90K | -472.20K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 117.09M | 117.09M | 117.09M | 117.09M | 117.09M |
| Average Diluted Shares Outstanding | 117.09M | 117.09M | 117.09M | 117.09M | 117.09M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
